NR4A2 and Parkinson disease: Nurr1 gene-modified MSCs significantly enhanced the pathological activity of PD rats 4 weeks after transplantation and increased the number of TH-positive cells in the substantia nigra (SN) and TH-positive striatum fibers, inhibited glial cell activation and decreased the expression of inflammatory factors in the SN (Wang et al., 2018).